Tesis dirigides (84) Tesis dirigides per membres de Departamento académico Mostra les tesis defensades

2024

  1. Evaluation of modified vaccinia virus Ankara based locoregional immunotherapy in peritoneal carcinomatosis models

    Bella Carreño, Ángela

    Dirigida per Pedro Berraondo López y Fernando Aranda Vega

2023

  1. Deep deconvolution of the haematopoietic stem cell regulatory microenvironment in health, ageing and malignant transformation

    Cenzano-Armendáriz, Itziar

    Dirigida per Felipe Prosper Cardoso y Borja Sáez Ochoa
  2. LncRNAs: Novel therapeutic targets to treat Multiple Myeloma with RNA-based therapies

    Amundarain, Ane

    Dirigida per Felipe Prosper Cardoso y Xabier Aguirre Ena
  3. Modelling, design, fabrication and characterization of engineered human myocardium made with melt electrowriting and cardiac cells derived from hipscs

    Flandes Iparraguirre, María

    Dirigida per Felipe Prosper Cardoso y Manuel María Mazo Vega
  4. Tailoring the bioactivities of IL-12 for cancer immunotherapy with mRNA-based technology: from immunocytokines to armored T cell transfer

    Di Trani, Claudia Augusta

    Dirigida per Pedro Berraondo López y Ignacio Melero Bermejo
  5. Tim-3 blockade as a therapeutic approach for diffuse intrinsic pontine Glioma

    Ausejo Mauleón, Iker

    Dirigida per Marta María Alonso Roldán y Fernando Pastor Rodríguez

2022

  1. Developing RNA sequences to regulate therapeutic genes expression

    ROVIRA BARREIRA, ERIC

    Dirigida per Fernando Pastor Rodríguez y Puri Fortes
  2. Multiomics characterization of immune cells for improved monitoring of response and resistance to immunotherapy in multiple myeloma

    Perez, Cristina

    Dirigida per Bruno Paiva y Juana María Merino Roncal
  3. Novel systems biology tools for the identification of biomarkers and drug targets in cancer research

    Valcárcel-García, Luis Vitores

    Dirigida per Francisco Javier Planes Pedreño y Xabier Aguirre Ena
  4. Synergistic effect of novel HDAC inhibitors with chemotherapy drugs in acute myeloid leukemia

    Gimenez Camino, Naroa

    Dirigida per Xabier Aguirre Ena y Francisco Javier Planes Pedreño
  5. Understanding niche-leukemia interactions: the bone marrow microenvironment regulates the metabolic and redox balance in acute myeloid leukemia stem cells

    Viñado-Solanas, A. C.

    Dirigida per José Juan Rifón Roca y Borja Sáez Ochoa

2021

  1. Biological characterization and clinical utility of circulating tumor cells in newly diagnosed multiple myeloma

    Garcés Latre, Juan José

    Dirigida per Bruno Paiva y María José Calasanz Abinzano
  2. Gene therapy and mRNA strategies to improve cytokine-based immunotherapy

    Fernández Fernández, Myriam

    Dirigida per Ignacio Melero Bermejo y Pedro Berraondo López
  3. Immunological characterization of monoclonal gammopathies using multidimensional and computational flow cytometry

    Da Silva Maia, Catarina Alexandra

    Dirigida per Bruno Paiva y Juana María Merino Roncal
  4. Targeting cd3 for immune modulation with rna aptamers

    Puravankara Menon, Ashwathi

    Dirigida per Fernando Pastor Rodríguez

2020

  1. Characterization of the lncrna transcriptome in multiple myeloma

    Carrasco Leon, Arantxa

    Dirigida per Xabier Aguirre Ena y Teresa Ezponda Itoiz
  2. Comprehensive DNA methylation profiling of chronic myeloproliferative neoplasms and discovery of zfp36l1, a novel tumour suppressor gene epigenetically regulated by enhacer dna methylation in myelofibrosis

    Martínez Calle, Nicolás

    Dirigida per Felipe Prosper Cardoso y Xabier Aguirre Ena
  3. Development of cellularized and funcionalized collagen scaffolds for the treatment of myocardial infarction

    Pérez Estenaga, Íñigo

    Dirigida per Beatriz Pelacho Samper
  4. Evaluación de enfermedad mínima residual en mieloma múltiple: Nuevos algoritmos para la estratificación pronóstica de pacientes mediante citometría de flujo multiparamétrica

    Arana Berganza, Paula

    Dirigida per José Juan Rifón Roca y Bruno Paiva
  5. Explotando SR-B1 para el desarrollo de nuevos fármacos para la inmunoterapia

    Tenesaca Cayambe, Shirley Mireya

    Dirigida per Pedro Berraondo López y Ignacio Melero Bermejo